![Global Fintech Investments Surged in 2018 with Investments in China Taking the Lead, Accenture Analysis Finds; UK Gains Sharply Despite Brexit Doubts | Accenture Global Fintech Investments Surged in 2018 with Investments in China Taking the Lead, Accenture Analysis Finds; UK Gains Sharply Despite Brexit Doubts | Accenture](https://newsroom.accenture.com//content/1101/images/Products.jpg)
Global Fintech Investments Surged in 2018 with Investments in China Taking the Lead, Accenture Analysis Finds; UK Gains Sharply Despite Brexit Doubts | Accenture
![From the comfort zone to crown dieback: Sequence of physiological stress thresholds in mature European beech trees across progressive drought - ScienceDirect From the comfort zone to crown dieback: Sequence of physiological stress thresholds in mature European beech trees across progressive drought - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0048969720353213-ga1.jpg)
From the comfort zone to crown dieback: Sequence of physiological stress thresholds in mature European beech trees across progressive drought - ScienceDirect
![Increased respiratory morbidity associated with exposure to a mature volcanic plume from a large Icelandic fissure eruption | Nature Communications Increased respiratory morbidity associated with exposure to a mature volcanic plume from a large Icelandic fissure eruption | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-22432-5/MediaObjects/41467_2021_22432_Fig1_HTML.png)
Increased respiratory morbidity associated with exposure to a mature volcanic plume from a large Icelandic fissure eruption | Nature Communications
![Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8ea337b1-88f6-47d6-b200-b808b0a3d84d/gr2_lrg.jpg)